Ivabradine for hemodynamic optimization and catecholamine weaning in cardiogenic shock: a retrospective cohort study
Heart rate control may represent a key therapeutic target in cardiogenic shock (CS), particularly in patients who experience failure of catecholamine weaning. Ivabradine, a selective sinus node inhibitor, could improve ventriculo-arterial coupling and hemodynamic stability; however, clinical data in this setting...